California Neuroscience Research specializes in studies of depression, migraines and memory loss.
Most of our memory loss studies have an age range of 50-90 years old.
Most of our other studies have an age range of 18-70 years old.
Currently enrolling studies are listed below. Please contact us for further information.
Major Depressive Disorder
California Neuroscience Research is conducting a research study to evaluate an investigational medication in persons with treatment resistant Major Depressive Disorder. Up to 13 weeks (10 visits). Please see link to learn more.
California Neuroscience Research is conducting a clinical research study to evaluate an investigational medication for Major Depressive Disorder added to ongoing anti-depressant. Investigational medication and all study-related services are provided at no cost. Certain medications and certain medical conditions are excluded. Treatment is administered intravenously.
Research study of an investigational medication in the acute treatment of Migraines. Up to 54 weeks (18 visits in total).
Research study of an investigational medication or placebo taken twice daily in subjects with Alzheimer’s Type Dementia and agitation. Up to 10 weeks (7 visits).
We are conducting an 18-month research study of an investigational medication vs. placebo (an inactive substance) for Early Alzheimer’s Disease.
Research study of an investigational medication (oral or infusion) vs. placebo in participants at risk for the onset of clinical symptoms of Alzheimer’s Disease. Length of Study: 1 visit for genetic testing (plus phone follow ups); up to 8 years for qualified subjects (up to 10 visits in year 1 and up to 4 visits in the following years).